Longview Ventures Asset Manager Profile - aVenture Research
Longview Ventures is a clinical-stage investment firm launched by the Leducq Trust in 2018 to invest in select portfolio companies of Broadview Ventures. The firm focuses on Series B and Series C financings, primarily targeting companies working on cardiovascular disease and stroke. This complements Broadview's focus on Seed and Series A investments, ensuring a continuum of support for innovative healthcare solutions.
Notable portfolio companies include Aria CV, AtaCor Medical, Basking Biosciences, and Comanche Biopharma. The investment team leverages its deep expertise in the cardiovascular sector to provide strategic guidance and support. Proceeds from Longview Ventures are dedicated to advancing the mission of the Leducq Charitable Trust, emphasizing a commitment to impactful healthcare advancements.
Portfolio Snapshot
Observed round participation, including acquisitions and grants. Current holdings, investor exits, and write-offs are not established.